Osaka, Japan

Hideyuki Maekawa


Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 64(Granted Patents)


Location History:

  • Osaka, JA (1976)
  • Osaka, JP (1979 - 1983)

Company Filing History:


Years Active: 1976-1983

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Hideyuki Maekawa

Introduction

Hideyuki Maekawa is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals and packaging through his innovative designs and formulations. With a total of 5 patents to his name, Maekawa continues to push the boundaries of technology and medicine.

Latest Patents

One of his latest patents is a glass vial with a diagonal cut line. This vial features a diagonally disposed cut line defined by off-set indentations in the neck portion, enhancing usability and functionality. Another significant patent is for a long-acting preparation of cefalexin, which is designed for effective treatments. This preparation is coated with a pH-dependent layer that dissolves in the upper intestine, allowing for concurrent administration with a normal cefalexin. The coated cefalexin is formulated in a unit-dosage form, such as capsules or tablets, ensuring ease of use for patients.

Career Highlights

Throughout his career, Hideyuki Maekawa has worked with prominent companies, including Shionogi & Company Limited and Shin-Etsu Chemical Co., Ltd. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical technology.

Collaborations

Maekawa has collaborated with notable colleagues, including Kaoru Ishitobi and Yasushi Takagishi. These partnerships have fostered a creative environment that has led to the development of groundbreaking inventions.

Conclusion

Hideyuki Maekawa's contributions to the fields of pharmaceuticals and packaging are noteworthy. His innovative patents and collaborations reflect his commitment to advancing technology for better healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…